BACKGROUND: Proper stratification of recurrence risk in breast cancer is crucial for guiding treatment decisions. This study aims to predict the recurrence risk of breast cancer patients using a multimodal deep learning model that integrates multiple...
OBJECTIVE: The aim of this study was to develop a multimodal fusion model for accurate risk prediction and clinical decision support for ductal carcinoma in-situ (DCIS).
BMC medical informatics and decision making
Oct 13, 2025
BACKGROUND: Breast cancer remains one of the leading causes of cancer-related deaths globally, affecting both women and men. This study aims to develop a novel deep learning (DL)-based architecture, the Breast Cancer Ensemble Convolutional Neural Net...
BACKGROUND: AI-based models for analysis of histopathology whole slide images (WSIs) are now common. However, image quality, particularly unsharp areas of WSIs, impacts model performance. In this study we investigate the impact of blur on deep learni...
Full-field digital mammography (FFDM) is the most common imaging technique for breast cancer screening programs. Still, it is limited by noise from quantum effects, electronic issues, and X-ray scattering, affecting the image quality. Traditional den...
PURPOSE: Segmentation of breast lesions in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is critical for effective diagnosis. This study investigates the impact of breast region segmentation (BRS) on the performance of deep learning-...
The purpose of this study was to investigate the relationship between coagulation related genes (CRGs) and breast cancer (BC). First, we found that most CRGs are abnormally expressed in BC patients and correlated with their prognosis. Therefore, we e...
As potential biomarkers for breast cancer, microRNAs (miRNAs) have demonstrated significant promise in clinical applications. However, accurate miRNA-based breast cancer diagnosis is hindered by the lack of simple, ultrasensitive, and highly specific...
Optimizing chemotherapy for breast cancer (BC) remains a critical challenge. Gut microbiota (GM) dysbiosis, varying across BC subtypes and stages, influences BC development and chemotherapy response through immune and metabolic pathways. Chemotherapy...
Breast cancer continues to be a global public health challenge. An early and precise diagnosis is crucial for improving prognosis and efficacy. While deep learning (DL) methods have shown promising advances in breast cancer classification from mammog...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.